Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Metformin Use in Chronic Kidney Disease: The CKD-Met Study
Brief Summary:
Metformin is the most widely prescribed oral treatment for diabetes, and the only one that showed a survival benefit.
Yet, there is no consensus on the optimal dose and withdrawal of metformin in chronic kidney disease (CKD) patients.
The aim of the study is to describe the use and side-effects of metformin in CKD patients in routine practice.